comparemela.com

Latest Breaking News On - Oslo cancer cluster innovation - Page 1 : comparemela.com

PCI Biotech Holding ASA: PCI Biotech fourth quarter and preliminary full year 2021 results

Oslo (Norway), 18 February 2022 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim Q4 and preliminary full-year 2021 results. Please find enclosed the report

United statesSouth koreaUnited kingdomSouth koreanRonny skuggedalBiotech holdingOlix pharmaceuticalsOslo cancer cluster innovationOslo cancer cluster innovation parkQuarterly reportNorwegian securities trading

Investegate |PCI Biotech Holding ASA Announcements | PCI Biotech Holding ASA: PCI Biotech fourth quarter and preliminary full year 2021 results

Investegate announcements from PCI Biotech Holding ASA, PCI Biotech fourth quarter and preliminary full year 2021 results

United statesSouth koreaUnited kingdomSouth koreanRonny skuggedalBiotech holdingOlix pharmaceuticalsOslo cancer cluster innovationOslo cancer cluster innovation parkQuarterly reportNorwegian securities tradingInvestegate announcementsInvestegate company announcementsPci biotech holding asaLobenewswire and globenewswire

Investegate |PCI Biotech Holding ASA Announcements | PCI Biotech Holding ASA: PCI Biotech: Invitation to Q4 2021 result presentation

Investegate announcements from PCI Biotech Holding ASA, PCI Biotech: Invitation to Q4 2021 result presentation

Ronny skuggedalBiotech holdingOslo cancer cluster innovationOslo cancer cluster innovation parkNorwegian securities tradingInvestegate announcementsInvestegate company announcementsPci biotech holding asaLobenewswire and globenewswire

vimarsana © 2020. All Rights Reserved.